Austin-based ArthroCare Corp. will resume trading Friday with the ticker ARTC.
The local medical device maker was delisted last year, but has since restored its exchange standing, officials said Tuesday afternoon. ArthroCare’s shares have been trading on Pink Sheets at about $24 in recent days.
The company's listing was degraded after the U.S. Securities and Exchange Commission and others questioned certain business practices.
CEO Mike Baker later resigned after an investigation discovered transgressions and insurance billing irregularities. Longtime board member David Fitzgerald was then named replacement president and CEO in October and Arthrocare implemented new ethics rules.
The minimally-invasive surgical products developer reported total revenue of $314.2 million in 2008 from $279.7 million the previous year.
•
del.icio.us
digg
facebook
E-mail this release to a friend (requires login).